office (813) 745-6239
fax (813) 745-6525


Economics is the science of human behavior in relation to choice. Cancer is a disease that involves many perplexing treatment choices. The emerging field of Cancer Economics examines the burden of cancer, as well as the choices patients must make and how they make them. For example, do cancer patients place different values on different health-related quality of life domains--such as pain, fatigue, and depression--than non-cancer patients? The primary goal of this lab is to "listen" to patients' preferences systematically so that we can better understand the burden of cancer and the treatments. This knowledge is critical for medical-decision making, treatment recommendations, and health policy, and, most importantly, the promotion and development of decision aids that incorporate the patient perspective. Dr. Craig and lab members consistently and systematically achieve this goal by conducting online surveys, economic evaluations, and secondary data analyses on a wide range of cancer-related topics. Dr. Craig has collaborated with a diverse group of peers (Moffitt Cancer Center researchers as well as national and international researchers) on a variety of funded and unfunded projects. (See CV).


Dr. Craig is the director of Craig Lab. In September 2011 the National Cancer Institute (NCI) awarded Dr. Craig a 5-year NIH R01 grant (R01CA160104) to conduct a national valuation study of the Patient-Reported Outcomes Measurement Information System--assessment tools that measure patient-reported health status--which was funded by the National Institutes of Health (NIH). Click here

Benjamin M. Craig, Ph.D.
Associate Member, Department of Health Outcomes and Behavior, Moffitt Cancer Center
Associate Professor of Economics at the University of South Florida 


Craig Lab provided support to Dr. Brandon with his NCI-funded (R01-CA134347) study examining the cost-effectiveness of extended self-help booklets for smoking cessation. Prior to this research, Craig Lab provided support to his analysis of the cost-effectiveness of relapse-prevention booklets as adjunct to a tobacco quitline (R01-CA137357).    

Thomas H. Brandon, Ph.D.
Chair, Program Leader, and Senior Member, Department of Health Outcomes and Behavior
Moffitt Cancer Center


Craig Lab collaborated with Dr. Lengacher on a study that looked at the cost-effectiveness of a Mindfulness-Based Stress Reduction program for improving quality of life in breast cancer survivors.

Cecile A. Lengacher, RN, PhD, FAAN
Faculty Member, Health Outcomes and Behavior Program, Breast Cancer Clinical Program and Population Sciences Division, Moffitt Cancer Center
Professor and Director of the BS-PhD Program, College of Nursing at the University of South Florida


Craig Lab collaborated with Dr. List on three analyses of Medicare claims data from the Surveillance Epidemiology and End Results (SEER) system, each of which examined the registration of patients diagnosed with hematologic disorders: 1) Assessment of accurate reporting of myeloid leukemias in the 1999-2008 SEER-Medicare database (abstract) 2) Incidence of myelodysplastic syndromes using the 2000-2008 SEER-Medicare database (abstract) and 3) Comparison of myelodysplastic syndrome patients registered versus not registered in SEER with regard to diagnostic testing, treatment, cost of care, and survival (abstract).

   Alan F. List, M.D.
   President and CEO of Moffitt Cancer Center
   Senior Member, Department of Malignant Hematology and the Experimental Therapeutics Program

Craig Lab recently submitted a Patient-Centered Outcomes Research Institute (PCORI) grant proposal with Dr. Magliocco to investigate “patient-centered strategies to reduce the diagnostic burden in breast cancer pathology.” Drs. Magliocco and Craig seek to identify the frequency and extent of diagnostic differences in referred specimens of  breast cancer patients treated at Moffitt Cancer Center and to assess patient burden of misdiagnoses. Additionally, they plan to model the comparative benefits and harms of alternative referral strategies in terms of reduced likelihood of improper medical treatment and reduced diagnostic burden. For this study, Craig Lab will be conducting a patient-centered online survey of approximately 1,000 U.S. women age 40 or older.

Anthony M. Magliocco, M.D., F.R.C.P.C., F.C.A.P.
Chair, Anatomic Pathology and Executive Director of Esoteric Laboratory Services
Moffitt Cancer Center


Craig Lab and Dr. Pidala developed an instrument to survey oncologists and hematologists using best-worst scaling of clinical vignettes that described a variety of patient characteristics to assess referral practices for hematopoietic cell transplantation (abstract).

Joseph A. Pidala, M.D., M.S.
Assistant Member, Blood and Marrow Transplant Department, Moffitt Cancer Center


Craig Lab recently collaborated with Dr. Poch on an American Cancer Society grant proposal, “Bladder Cancer: Association of smoking status and tumor stage and grade by cotinine levels” and, most recently, on the submission of an NIH R01 proposal to examine the burden of adverse events experienced by men treated for prostate cancer.

Michael A. Poch, M.D.
Assistant Member, Department of Geniotourinary Oncology, Moffitt Cancer Center


Craig Lab and Dr. Reed examined pregnancy preferences (abstract) and are actively collecting data in an online survey to assess the association between meningioma and pregnancy. Specifically, U.S. women age 18 and older who have had a meningioma in the past are being asked about their meningioma diagnosis(es) and treatment, whether or not they want or plan to have additional children (if possible), and whether or not having had (or currently having) a meningioma influences their pregnancy decisions. Additionally, Craig Lab is actively involved in the Adolescent Young Adult (AYA) program at Moffitt, directed by Dr. Reed.

Damon R. Reed, M.D.
Assistant Member, Sarcoma Program, Moffitt Cancer Center